[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369706-105":59,"doc-detail-369706-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cytidine-diphosphate-diacylglycerol-synthase-2-is-a-synthetic-lethal-target-in-mesenchymal-like-cancers","Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers","","Cytidine diphosphate diacylglycerol synthase 2 (CDS2) is identified as a cancer-specific synthetic lethal target using differential RNA expression and computational functional genomics. Analyses reveal a robust CDS1–CDS2 interaction present in mesenchymal-like cancers, where CDS1 expression is low or absent, and where CDS2 loss triggers apoptosis. Mechanistically, the interaction disrupts lipid homeostasis with accumulation of cholesterol esters and triglycerides. Genome-wide CRISPR–Cas9 screens in CDS1-negative cells show no common escape mechanism, and lethality depends on CDS2 dosage and catalytic activity, supporting pharmacological tractability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cytidine-diphosphate-diacylglycerol-synthase-2-is-a-synthetic-lethal-target-in-mesenchymal-like-cancers/369706/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cytidine-diphosphate-diacylglycerol-synthase-2-is-a-synthetic-lethal-target-in-mesenchymal-like-cancers/369706.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What synthetic lethal interaction was uncovered in this study?","Question",{"text":112,"@type":113},"The study identifies a cancer-specific synthetic lethal interaction between the paralogs CDS1 and CDS2.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are mesenchymal-like cancers particularly sensitive to CDS2 loss?",{"text":117,"@type":113},"Mesenchymal-like cancers have low or absent CDS1 expression, making cells dependent on CDS2 for survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the robustness of the CDS1–2 synthetic lethal relationship?",{"text":121,"@type":113},"Genome-wide CRISPR–Cas9 knockout screens in CDS1-negative cancer cells show no common escape mechanism after CDS2 ablation, and lethality depends on CDS2 dosage and catalytic activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369706,1790218765,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","nature genetics  \nArticle [https://doi.org/10.1038/s41588-025-02221-2](https://doi.org/10.1038/s41588-025-02221-2)  \nCytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers  \nReceived: 17 November 2023  \nAccepted: 9 May 2025  \n\n| Published online: 4 July 2025 |\n| --- |\n|  Check for updates |\n\nTim Arnoldus  1, Alex van Vliet  1, Onno B. Bleijerveld  2,  \nAdriaan F. H. deGroot1, Qinglin Piao1, Niek Blomberg3, DésiréeSchatton  4, Jing Dong  1, Susan E. van Hal-van Veen1, Rolf Harkes5, Anita E. Grootemaat6, Natalie Proost7, Birol Cabukusta8, Christian Frezza  4,9, Marieke van deVen7, Nicole N. van derWel6, Martin Giera  3, Maarten Altelaar  2,10 &  \nDanielS. Peeper  1   \nSynthetic lethal interactions (SLIs) based on genomic alterationsin cancer have been therapeutically explored. We investigated the SLI space asa function of differential RNA expression in cancer and normal tissue. Computational analyses of functional genomic and gene expression resources uncovered a cancer-specific SLI between the paralogs cytidine diphosphate diacylglycerol synthase 1 (CDS1) and CDS2. The essentiality of CDS2 for cell survival is observed formesenchymal-like cancers, which have low or absent CDS1 expression and account for roughly half of all cancers. Mechanistically, the CDS1–2 SLI is accompanied by disruption of lipid homeostasis, including accumulation of cholesterol estersand triglycerides, and apoptosis. Genome-wide CRISPR–Cas9 knockout screensinCDS1-negative cancer cells identify no common escape mechanism of death caused by CDS2 ablation, indicating the robustness of the SLI. Synthetic lethality is driven by CDS2 dosage and depends on catalytic activity. Thus, CDS2 may serve asapharmacologically tractable target in mesenchymal-like cancers.  \nSLIs can provide a therapeutic index in cancer1, as exemplified by the dependency on poly(ADP-ribose) polymerase (PARP) ofBRCA-deficient hereditary breast and ovarian cancer. Whereas healthy cells retain one functional germline BRCA copy, somatic loss of the second copy results in cancer. As BRCA deficiency results in loss of homology-based DNA repair2, it causes a strong dependency on PARP for genomic stability and, hence, survival. This SLI has been clinically exploited with specific PARP inhibitors3–5. This clinical success, and other examples, have spurred efforts to identify additional cancer-associatedSLIs6–32. Similar to BRCA–PARP, data on genomic alterations specific to cancer are commonly used to find SLIs2–4,6–19,31, such as the dependency on WRNin microsatellite unstable cancers6,7.  \nIn addition to genomic alterations, cancers also have distinct gene expression profiles relative to healthy tissue. Publicly available datasets provide extensive transcriptional information as well as genetic dependencies in cancer. For example, the cancer Dependency Map (DepMap) is a comprehensive research initiative providing matched CRISPR screening and gene expression data for 913 cell lines across 30 cancer lineages (2021Q2)33,34. In addition, the Cancer Genome Atlas (TCGA) provides genome-wide gene expression data for 9,264 tumor and 741 healthy samples35. Together, these datasets provide 250 million datapoints on gene expression and genetic dependencies in cancer and can be mined to predict SLIs. For example, gene expression data have been used to retrospectively predict  \nA full list of affiliations appears at the end of the paper. [e-mail:](e-mail: d.peeper@nki.nl)[ d.peeper@nki.nl](e-mail: d.peeper@nki.nl)  \npatient responses to targeted therapy using computational synthetic lethality analyses29.  \nHere, we performed unbiased computational analyses to find cancer-specific SLIs, taking advantage of these public functional genomic and gene expression resources, particularly the GenotypeTissue Expression (GTEx) project, which provides genome-wide gene expression data for 17,382 healthy tissue samples36. We scored all~340 million gene pairs for synthetic le","cbCaio4BWQ03X41X","https://ap.wps.com/l/cbCaio4BWQ03X41X","pdf",11446917,35,"English","# Abstract\n## Synthetic lethal interactions and datasets\n## Computational pipeline and scoring\n## Anchor–target gene pairs\n## Results: CDS1–CDS2 synthetic lethal pair","[{\"question\":\"What synthetic lethal interaction was uncovered in this study?\",\"answer\":\"The study identifies a cancer-specific synthetic lethal interaction between the paralogs CDS1 and CDS2.\"},{\"question\":\"Why are mesenchymal-like cancers particularly sensitive to CDS2 loss?\",\"answer\":\"Mesenchymal-like cancers have low or absent CDS1 expression, making cells dependent on CDS2 for survival.\"},{\"question\":\"What evidence supports the robustness of the CDS1–2 synthetic lethal relationship?\",\"answer\":\"Genome-wide CRISPR–Cas9 knockout screens in CDS1-negative cancer cells show no common escape mechanism after CDS2 ablation, and lethality depends on CDS2 dosage and catalytic activity.\"}]","Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers | PDF",1790184165,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d19cce585ca943b54c96f3e5e1e611b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce33a380d172e334a5477e786e167ebc.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d97736d1831f9470d3053700b651da.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4308a6026e608eafab3927facae5d71.webp",980,1301]